Please login to the form below

Not currently logged in
Email:
Password:

ulcerative colitis

This page shows the latest ulcerative colitis news and features for those working in and with pharma, biotech and healthcare.

Lilly reports positive data from its phase 3 ulcerative colitis trial

Lilly reports positive data from its phase 3 ulcerative colitis trial

Eli Lilly’s IL-23 blocker mirikizumab has hit the mark in a phase 3 study in ulcerative colitis (UC), helping patients to achieve clinical remission 12 weeks after initiating treatment. ... Skyrizi is also being evaluated in a phase 2/3 trial for

Latest news

More from news
Approximately 22 fully matching, plus 125 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 5 fully matching, plus 10 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics